WILMINGTON, MA — Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced that its QS-B220 desktop explosives and drugs trace detector has won the 2015 GSN Homeland Security Award for “Best Explosive Detection Product or Solution” for the third year in a row. The QS-B220 also won the GSN Airport/Seaport/Border Security Award for “Best Security Checkpoint” in June 2015.
The GSN Homeland Security Awards are sponsored by Government Security News, a leading publisher of government and homeland security news. The GSN 2015 Homeland Security Awards Program was organized to honor the distinguished vendors of IT Security and Physical Security products and solutions and the dedicated federal, state, county and municipal government agencies, whose combined efforts keep our nation secure. Now in its 7th year, the GSN Homeland Security Awards Program is widely considered to be one of the most prestigious awards programs covering the broad Homeland Security field.
“As the saying goes, security has to be right 100% of the time and terrorists only have to be right once. Implant Sciences prides itself in having superior detection performance with the lowest False Alarm Rate (FAR) in the industry,” stated Robert Liscouski, President of Implant Sciences. “We are honored to have been selected by GSN, once again, for the GSN Homeland Security Awards.”
“Implant Sciences has had an incredible year, with its leading technology being adopted all around the world by the highest profile customers. Being selected as the “Best Explosive Detection Product of Solution” by GSN for the third year in a row is another sign that our trace detection technology has been recognized as the new standard in the market,” added Dr. Darryl Jones, Executive Vice President of Implant Sciences.
About the QS-B220 Desktop Explosives Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company’s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 70 countries worldwide. The Company’s ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior. It has also received the 2015 GSN Airport/Seaport/Border Security Award for “Best Security Checkpoint.” All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company’s website at http://www.implantsciences.com.
(NOTE: The above press release is from Implant Sciences.)
Like Wilmington Apple on Facebook! Follow Wilmington Apple on Twitter! Subscribe to Wilmington Apple’s daily email newsletter HERE! Got a comment, question, photo, press release, or news tip? Email wilmingtonapple@gmail.com!
Wilmington Apple 